Equities
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)8.00
  • Today's Change0.14 / 1.78%
  • Shares traded1.37m
  • 1 Year change+12.04%
  • Beta1.0004
Data delayed at least 15 minutes, as of Sep 20 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments5,9095,0464,206
Total Receivables, Net1,260975825
Total Inventory898658588
Prepaid expenses8810380
Other current assets, total----0
Total current assets8,1556,7825,699
Property, plant & equipment, net1,2051,2171,252
Goodwill, net166166166
Intangibles, net334766
Long term investments------
Note receivable - long term------
Other long term assets----0
Total assets9,5748,2327,204
LIABILITIES
Accounts payable485309229
Accrued expenses------
Notes payable/short-term debt30000
Current portion long-term debt/capital leases0.976.537.59
Other current liabilities, total1,6481,350862
Total current liabilities2,4341,6661,098
Total long term debt0.360.917.32
Total debt3017.4415
Deferred income tax161925
Minority interest------
Other liabilities, total89164172
Total liabilities2,5391,8491,302
SHAREHOLDERS EQUITY
Common stock888888
Additional paid-in capital422422422
Retained earnings (accumulated deficit)7,1046,4515,970
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity7,0356,3835,901
Total liabilities & shareholders' equity9,5748,2327,204
Total common shares outstanding827827827
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.